SPL 1.05% 9.6¢ starpharma holdings limited

Ann: US patent issued for DEP cabazitaxel nanoparticle, page-26

  1. 321 Posts.
    lightbulb Created with Sketch. 84
    At least this shows again that the SPL IP team can deliver commercially valuable Patents and should be greatly acknowledged and rewarded for achieving what is the lifeblood of a biotech. With no patents we would be up Sh** creek. So well done to that woman from the website is Dr Shubb. Taking all the great lab research and turning it into a marketable asset is a big achievement. But I want to know can the CEO and commercial team take the next step and turn it into dollars with a lisense partner.
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.6¢
Change
0.001(1.05%)
Mkt cap ! $40.06M
Open High Low Value Volume
9.7¢ 9.7¢ 9.6¢ $12.27K 126.8K

Buyers (Bids)

No. Vol. Price($)
2 3994 9.6¢
 

Sellers (Offers)

Price($) Vol. No.
9.7¢ 6291 1
View Market Depth
Last trade - 13.38pm 09/09/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.